The global commitment to patient safety and increasingly complex drug pipelines are igniting an unprecedented boom in the Pharmacovigilance (PV) market. According to recent industry analysis, the market, valued at USD 8,813.6 million in 2023, is projected to soar to a remarkable USD 27,768.5 million by 2031. This staggering expansion represents a robust Compound Annual Growth Rate (CAGR) of...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek